ABIONYX Pharma SA (EPA:ABNX)
3.270
-0.025 (-0.76%)
Mar 9, 2026, 5:35 PM CET
ABIONYX Pharma Market Cap
ABIONYX Pharma has a market cap or net worth of €116.24 million as of March 9, 2026. Its market cap has increased by 151.66% in one year.
Market Cap
116.24M
Enterprise Value
116.98M
Revenue
4.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.27
Market Cap Chart
Since March 30, 2015, ABIONYX Pharma's market cap has decreased from 214.16M to 116.24M, a decrease of -45.72%. That is a compound annual growth rate of -5.43%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sensorion | 121.04M |
| Adocia | 123.44M |
| MaaT Pharma | 128.33M |
| Innate Pharma | 130.28M |
| OSE Immunotherapeutics | 90.09M |
| Valerio Therapeutics Société anonyme | 70.15M |
| Transgene | 224.54M |
| Cellectis | 228.55M |